Food News and Research

RSS

Health risks of wooden pallet shipping platforms, call for Congress and FDA regulation

The expanded recall of TYLENOL Arthritis pain reliever is fresh evidence of the need for Congress and the FDA to regulate wood pallets used to transport food and pharmaceuticals in the United States because of the dangers they pose to human health.

4 Jan 2010

China Yongxin Pharmaceuticals announces projected financial results for 2009

China Yongxin Pharmaceuticals, Inc., a leading manufacturer, distributor and retailer of Chinese traditional medicines, pharmaceutical products, natural health products, health food, cosmetics, and medical equipment in Northeastern China, today announced its projected financial results for the year ending December 31, 2009.

4 Jan 2010

Publix Super Markets issues voluntary recall for Publix Pumpkin Pecan Streusel Pie

Publix Super Markets is issuing a voluntary recall for Publix Pumpkin Pecan Streusel Pie, because it was mislabeled and may contain undeclared pecans. People who have an allergy or severe sensitivity to pecans run the risk of allergic reaction if they consume this product.

31 Dec 2009

Novartis Pharmaceuticals Canada named one of the top employers in Quebec

For the sixth time, Novartis Pharmaceuticals Canada Inc. has been named one of the top employers in Quebec, according to the newly released 2010 annual report of Hewitt's 50 Best Employers in Canada. This is due in large part to the high level of engagement of its 750 employees across Canada, including 350 at its head office in Dorval.

31 Dec 2009

MEPREP to fund research to study the effects of medication in pregnant women

A new research program called the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP) will fund research to study the effects of prescription medications used during pregnancy.

31 Dec 2009

BioElectronics announces product gains in international market; expects significant revenue in 2010

BioElectronics Corp., the maker of inexpensive, disposable, drug-free anti-inflammatory devices, today announces product gains in the international market as well as new international distributor and marketing partnerships. As a result, BioElectronics is expecting significant gains in international markets throughout 2010.

31 Dec 2009

FDA approves distribution of ZOLL E Series Monitor/Defibrillator

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new model of the ZOLL E Series® Monitor/Defibrillator with carbon monoxide (CO) measurement. The product is immediately available for shipment.

31 Dec 2009

Pfizer provides update on Prevnar 13

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has not yet completed its review of the Biologics License Application (BLA) for Prevnar 13™, (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company’s candidate 13-valent pneumococcal conjugate vaccine.

31 Dec 2009

Research suggests high-dose Vitamin E supplements may do more harm than good

Vitamin-fortified foods and dietary health supplements can ease health worries. But what kinds of vitamins are right for you? And how much of them should you take, and how often?

31 Dec 2009

Food addiction remains largely ignored but can be easily overcome, says psychologist

As holiday parties give way to New Year's resolutions, rehabs across the country become inundated, making early January one of the industry's busiest times of the year.

31 Dec 2009

Dr. Ken Hopper of LifeSynch offers simple tips toward achieving New Year's weight loss resolution

It's that time of year. Gyms will be flooded with people ready to step on a treadmill. Grocery carts will be filled with fruits and vegetables instead of frozen pizza and chips. People will enter the New Year resolved to lose weight. But surveys show that most people don't keep this resolution.

31 Dec 2009

FDA evaluates Phase III randomized trial in acute myeloid leukemia

VION PHARMACEUTICALS, INC., announced today that the U.S. Food and Drug Administration ("FDA") had responded to its Special Protocol Assessment ("SPA") request to evaluate the Phase III randomized trial HOVON AML 92 sponsored by the Dutch-Belgian Cooperative Group for Hematology Oncology ("HOVON") of its lead product Onrigin(TM).

31 Dec 2009

Website explores pros and cons of obesity

ProCon.org, a nonpartisan 501(c)3 nonprofit public charity dedicated to promoting critical thinking, created the new website http://www.obesity.procon.org to explore the core question "Is obesity a disease?"

30 Dec 2009

FDA accepts NDA review for new anticonvulsant drug

The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.

30 Dec 2009

Biodel submits NDA to FDA for clearance to market VIAject

Biodel, Inc. announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for clearance to market VIAject® as a treatment for diabetes.

30 Dec 2009

UB neurobiologist studies the impact of acute and chronic caffeine consumption in young people

Caffeine is a stimulant drug, although legal, and adults use it widely to perk themselves up: Being "addicted" to caffeine is considered perfectly normal.

30 Dec 2009

J&JPRD receives FDA Complete Response Letter for ceftobiprole

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) today announced it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for ceftobiprole. The New Drug Application (NDA) was originally submitted to the FDA in May 2007 for the treatment of complicated skin and skin structure infections (cSSSI), including diabetic foot infections.

30 Dec 2009

Nutrisystem to take non cash charge of $5 million as impairment charge

Nutrisystem, Inc., a leading provider of weight management products and services, today announced that it expects to take a non cash charge of up to $5 million before taxes to reflect an impairment charge on the value of the goodwill and identifiable intangibles related to its Nu-Kitchen fresh food delivery business that currently services the New York City area, which the company acquired in July 2008.

30 Dec 2009

NYBC calls for blood donation in recognition of National Blood Donor Month

New York Blood Center (NYBC) and its divisions in Manhattan, Long Island, Hudson Valley, Brooklyn/Staten Island, and New Jersey call upon the community to please donate blood, in recognition of National Blood Donor Month, and to help save lives.

30 Dec 2009

Santarus submits rifamycin SV MMX IND to the FDA

Santarus, Inc., a specialty biopharmaceutical company, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) requesting approval to begin a Phase III clinical program evaluating rifamycin SV MMX® in patients with travelers’ diarrhea.

30 Dec 2009